 Modified drug release dosage forms:  These dosage forms are designed to release drugs in a controlled manner, at a predetermined rate, duration and.

Slides:



Advertisements
Similar presentations
HOW DO DRUGS GET INTO THE BODY?. WHY BE CONCERNED ABOUT HOW DRUGS GET INTO BODY? Bioavailability - % of dose that gets into body Bioequivalence - similarity.
Advertisements

Osmotic Pressure-Controlled Gastrointestinal Delivery System
Pharmacokinetics of Drug Absorption
MODIFIED RELEASE DOSAGE FORM
Pharmacokinetics & Pharmacodynamics of Controlled Release Systems Presented By: Govardhan.P Dept. of pharmaceutics, University College of Pharmaceutical.
Week 5- Pharmacokinetics of oral absorption
ABSORPTION OF DRUGS DR.SOBAN SADIQ.
Practical Pharmacokinetics
Pharmacokinetics Based on the hypothesis that the action of a drug requires presence of a certain concentration in the fluid bathing the target tissue.
Pharmacokinetic introduction
ERT 420 BIOPHARMACEUTICAL ENGINEERING ERT 420 BIOPHARMACEUTICAL ENGINEERING Semester 1 Academic Session 2012/2013 HUZAIRY HASSAN School Of Bioprocess Engineering.
CLEARANCE (CL) describes the efficiency of irreversible elimination of a drug from the body by excretion of unchanged drug. Metabolic conversion of the.
Nonlinear Pharmacokinetics
You have learned a LOT so far. A few extra facts to throw in No single reproducible abnormality in any NT, enzyme, receptor or gene has been found to.
Lecture 2.  Clearance Ability to eliminate the drug  Volume of distribution (Vd) The measure of the apparent space in the body available to contain.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 3 Therapeutic Range.
Bioavailability Dr Mohammad Issa.
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
PHARMACOKINETICS CH. 4 Part 2. GETTING IN ABSORPTION Definition – the movement of a drug from the site of administration into the fluids of the body.
Pharmacokinetics of Drug Absorption Prepared by: KAZI RASHIDUL AZAM.
1 Controlled drug release Dr Mohammad Issa. 2 Frequency of dosing and therapeutic index  Therapeutic index (TI) is described as the ratio of the maximum.
Core Concepts in Pharmacology Chapter 5 Pharmacokinetics.
CHEE 4401 Definitions drug - any substance that affects the structure or functioning of an organism pharmaceutics - the area of study concerned with the.
Chapter 3 Sources and Bodily Effects of Drugs. Copyright © 2007 by Thomson Delmar Learning. ALL RIGHTS RESERVED.2 Sources of Drugs Plants Minerals Animals.
Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy University of Andalas.
1 Single-dose kinetics Plasma [Drug] curve Upon administration [drug] plasma reaches a max Then begins to decline as the Drug is eliminated Cp max = max.
Pharmaceutics I صيدلانيات 1 Unit 2 Route of Drug Administration
CHAPTER 7 ABSORPTION KINETICS.
PHARMACOKINETICS Definition: quantitative study of drug absorption, distribution, metabolism, and excretion (ADME), and their mathematical relationship.
INTRODUCTION CLINICAL PHARMACOKINETICS
Introduction What is a Biowaiver?
Prof. Dr. Henny Lucida, Apt
Pharmacokinetics of Drug Absorption Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University.
Modified release products. Considerations in the evaluation of modified release products Requirements for preparing extended release products. The bioavailability.
Design of Sustained Release Dosage Forms
PHT 415 BASIC PHARMACOKINETICS
Test Undergraduate – 24 Questions: Multiple Choice, Fill-in and T/F – 3 Problems MS – 3 Questions: Multiple Choice, Fill-in and T/F – MS grade: Undergrad.
INTRODUCTION TO PHARMACOKINETICS M. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague, Charles University in Prague,
Formulation of an oral dosage form utilizing the properties of cubic liquid crystalline phases of glyceryl monooleate Ref.: European Journal of Pharmaceutics.
1/20 PRESENTED BY BRAHMABHATT BANSARI K. M. PHARM DEPARTMENT OF PHARMACEUTICS AND PHARMACEUTICAL TECHNOLGY L. M. COLLEGE OF PHARMACY.
7/2/ :52 AM 1 Reaction kinetics By A. S. Adebayo, Ph. D.
Physiological factors affecting drug absorption (continued)
routes of drug administration By Hawra alsofi
Chapter 8 BIOAVAILABILITY & BIOEQUIVALENCE
Pharmacology I BMS 242 Lecture II (Continued)
Introduction What is a Biowaiver?
Introduction of Biopharmaceutics & Pharmacokinetics
Doses and Terminology Part 1
The fraction of drug absorbed using the Wagner–Nelson method may be used to distinguish between the first-order drug absorption rate of a conventional.
Bioavailability of a drug from an immediate-release tablet containing 50 mg of drug given at 0, 4, and 8 hours compared to a single 150-mg drug dose given.
The fraction of drug absorbed using the Wagner–Nelson method may be used to distinguish between the first-order drug absorption rate of a conventional.
Biopharmaceutics of modified release drug products
Biopharmaceutics factors affecting Modified release products
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
Controlled drug release
Pharmaceutics 2.
Pharmacology I BMS 242 Lecture II (Continued)
Oral Sustained & Controlled Drug Delivery System
Clinical Pharmacokinetics
Firdaus | Sofia | Nurainiza | Hafizah
Pharmacokinetics and Factors of Individual Variation
Clinical Pharmacokinetics
Pharmacokinetics: Drug Absorption
Drug Delivery Systems Pharmaceutical technology Petra University.
Basic Biopharmaceutics
Pharmacologic Principles (Lilley, p. 16)
Therapeutic Drug Monitoring chapter 1 part 1
Pharmacokinetics.
Pharmacokinetics: Drug Absorption
Presentation transcript:

 Modified drug release dosage forms:  These dosage forms are designed to release drugs in a controlled manner, at a predetermined rate, duration and location to achieve and maintain optimum therapeutic levels of drug.

 sustained release (SR)  prolonged action  controlled release (CR)  extended release (ER)  modified release  timed release  long acting

Drugs that have neither very slow nor very fast rates of absorption and excretion Drugs that have uniform absorption in the GI tract Drugs that have small doses (less than 500mg) Drugs with a wide therapeutic index Drugs for chronic disease conditions

First-order kinetics Zero-order kinetics

The process that takes place at a constant rate independent of drug concentration involved in process Rate of process cannot be increased even the drug concentration is increased

The process that is directly proportional to the drug concentration involved in process Rate of process increases linearly with increase in drug concentration

Biopharmaceutical factors Dosage form selection

Stomach Small intestine Large intestine

Dissolution of drug in stomach may be affected by presence or absence of food

Basic pH, large surface area and presence of bacterial flora may affect the absorption of drug

Not much is known about drug absorption in this area although unabsorbed drug that reaches the area are metabolized by bacteria.

To minimize risk of rapid stomach absorption To release the drug immediately